tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ARCT Stock Latest News

Arcturus Therapeutics price target lowered to $86 from $87 at Canaccord
The FlyArcturus Therapeutics price target lowered to $86 from $87 at Canaccord
1d ago
ARCT
Arcturus Therapeutics expects cash runway to extend through Q1 of FY27
PremiumThe Fly
Arcturus Therapeutics expects cash runway to extend through Q1 of FY27
3d ago
ARCT
Arcturus Therapeutics reports Q1 EPS ($1.00), consensus ($1.19)
PremiumThe Fly
Arcturus Therapeutics reports Q1 EPS ($1.00), consensus ($1.19)
3d ago
ARCT
ARCT Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ARCT Earnings this Week: How Will it Perform?
5d ago
ARCT
Arcturus Therapeutics’ Kostaive® Vaccine Succeeds in Phase III
PremiumCompany Announcements
Arcturus Therapeutics’ Kostaive® Vaccine Succeeds in Phase III
2M ago
8K
ARCT
Arcturus Therapeutics price target raised to $87 from $81 at Canaccord
PremiumThe FlyArcturus Therapeutics price target raised to $87 from $81 at Canaccord
2M ago
ARCT
Arcturus Therapeutics price target raised to $58 from $45 at Wells Fargo
PremiumThe Fly
Arcturus Therapeutics price target raised to $58 from $45 at Wells Fargo
2M ago
ARCT
Arcturus Therapeutics reports Q4 EPS (32c), consensus (99c)
PremiumThe Fly
Arcturus Therapeutics reports Q4 EPS (32c), consensus (99c)
2M ago
ARCT
ARCT Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ARCT Earnings this Week: How Will it Perform?
2M ago
ARCT
Options Volatility and Implied Earnings Moves This Week, March 04 – March 07, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves This Week, March 04 – March 07, 2024
2M ago
FL
KR
EC grants ‘orphan medicinal product designation’ to Arcturus’ ARCT-032 for CF
PremiumThe Fly
EC grants ‘orphan medicinal product designation’ to Arcturus’ ARCT-032 for CF
3M ago
ARCT
ARCT: Why Have Analysts Rated this Small-Cap Biotech Stock a “Strong Buy”?
PremiumStock Analysis & Ideas
ARCT: Why Have Analysts Rated this Small-Cap Biotech Stock a “Strong Buy”?
3M ago
PFE
ARCT
Arcturus Therapeutics price target raised to $48 from $40 at Citi
PremiumThe FlyArcturus Therapeutics price target raised to $48 from $40 at Citi
3M ago
ARCT
Arcturus Therapeutics management to meet with Piper Sandler
PremiumThe Fly
Arcturus Therapeutics management to meet with Piper Sandler
3M ago
ARCT
Arcturus Therapeutics management to meet with Piper Sandler
PremiumThe Fly
Arcturus Therapeutics management to meet with Piper Sandler
3M ago
ARCT
Arcturus Therapeutics’ and CSL’s COVID-19 vaccine shows longer immune response
PremiumThe Fly
Arcturus Therapeutics’ and CSL’s COVID-19 vaccine shows longer immune response
3M ago
ARCT
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
MOR
ALLK
3 Best Stocks to Buy Now, 1/15/2024, According to Top Analysts 
PremiumStock Analysis & Ideas
3 Best Stocks to Buy Now, 1/15/2024, According to Top Analysts 
4M ago
PDS
ARCT
PassPort Technologies starts collaborative research with Arcturus Therapeutics
PremiumThe Fly
PassPort Technologies starts collaborative research with Arcturus Therapeutics
4M ago
ARCT
The biotech stocks to own in 2024, according to Piper Sandler
PremiumThe FlyThe biotech stocks to own in 2024, according to Piper Sandler
4M ago
ALT
ALGS
Arcturus Therapeutics and CSL’ ARCT-154 shows superior immunogenicity
PremiumThe Fly
Arcturus Therapeutics and CSL’ ARCT-154 shows superior immunogenicity
5M ago
ARCT
Arcturus Therapeutics, CSL publish data on booster dose of ARCT-154
PremiumThe Fly
Arcturus Therapeutics, CSL publish data on booster dose of ARCT-154
5M ago
ARCT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >